A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.
about
Fecal calprotectin in inflammatory bowel diseaseDisease monitoring in inflammatory bowel diseaseThe role and utility of faecal markers in inflammatory bowel disease.Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren's syndrome and rheumatoid arthritis.Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.The use of fecal calprotectin as a biomarker in gastrointestinal disease.Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn's disease.A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.Luminally expressed gastrointestinal biomarkers.Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission.Noninvasive Markers of Disease Activity in Inflammatory Bowel Disease.The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.Comparison of Fecal Inflammatory Markers in Crohn's Disease.Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.Faecal calprotectin for differentiating between irritable bowel syndrome and inflammatory bowel disease: a useful screen in daily gastroenterology practice.Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.Correlation Between Calprotectin and Modified Rutgeerts Score.Effect of oral diclofenac intake on faecal calprotectin.Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceFecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopyFrom bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
P2860
Q26766527-16F55321-2A0A-4A73-9B51-139A44BEE2DAQ26777553-F242EE4B-E791-4680-84B5-4EF7BAE9392FQ34456258-96D16F17-0D23-4931-81CA-61218AA03AEDQ37689925-783824E9-8FC8-4762-B5AB-5EB80BA768BCQ37698552-C3930640-7C0F-4351-8D6E-2528F7D8F1E4Q38171862-45118E49-709F-45C6-AF21-EF70B5B44259Q38219444-02927AFE-F5E7-4973-A72A-8FF21FD793B8Q38344883-AF44C827-ADCA-469C-9F5D-CEF991B4A450Q38384730-872A67F8-A14E-474F-B320-49E7517D217FQ38636313-3426AE50-D622-4887-A746-8ECD734E59ABQ38641380-C40C06AB-E8B9-4F7F-AEE9-CB0308DFC66FQ38657630-D8519F10-EADB-4CAE-9AA4-5077BFF42700Q38774391-C169D38C-723F-4C29-BAEC-F9AA7C04CAD9Q38789632-C0DA21F6-70EB-44A4-A3D8-BFF5FB1AB876Q38950426-6D589802-B405-4D8E-A162-F3A3D5AD2197Q38990506-C918AB9C-3CBA-4C51-9A51-8661938AA2EBQ39464033-0336232E-4448-451F-A76F-5C2AF1005606Q39612269-81F70EDB-8A2E-45FF-8F34-D90D3889BAAAQ40052049-194B916F-54CD-4828-A428-3A2BD80420AFQ41608430-B4919D84-4246-431A-91B5-CE7D044B1FC3Q42250900-318C645A-03F0-4CDC-8485-D5D5E449221CQ42293563-3CDF7E5B-8EEC-4D82-B8B2-2D46B5D1F496Q43319924-4491C4A6-EA72-4523-B91C-7409F7A90A71Q48147122-87156736-13FB-4ED0-A78D-BEEF03AADBC3Q51618737-6FF97BD6-53E4-4DB1-AA4A-2DD658A0C2C3Q52983772-E8895F76-E9A9-403B-8473-AF22A6443167Q53610108-52F84ED2-06EF-4BAE-8582-442B97CD066CQ55287522-0488AA21-3448-4136-BB6A-5C6349FF2839Q57063313-5F47DBE1-247F-4120-9425-5A33931511ABQ57109774-772CC02B-EF65-454A-B5E7-3EBE58FD631BQ58760402-37F19F19-C391-4EDD-9ECA-075D7EA577E6
P2860
A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A prospective single-centre ev ...... in quiescent Crohn's disease.
@en
A prospective single-centre ev ...... in quiescent Crohn's disease.
@nl
type
label
A prospective single-centre ev ...... in quiescent Crohn's disease.
@en
A prospective single-centre ev ...... in quiescent Crohn's disease.
@nl
prefLabel
A prospective single-centre ev ...... in quiescent Crohn's disease.
@en
A prospective single-centre ev ...... in quiescent Crohn's disease.
@nl
P2093
P2860
P356
P1476
A prospective single-centre ev ...... n in quiescent Crohn's disease
@en
P2093
A J Morris
G D Naismith
J W Winter
P2860
P304
P356
10.1111/APT.12221
P407
P50
P577
2013-01-24T00:00:00Z